109 related articles for article (PubMed ID: 10735512)
1. Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression.
Scholl FA; Betts DR; Niggli FK; Schäfer BW
Br J Cancer; 2000 Mar; 82(6):1239-45. PubMed ID: 10735512
[TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
3. Alterations in gene expression profiles during prostate cancer progression: functional correlations to tumorigenicity and down-regulation of selenoprotein-P in mouse and human tumors.
Calvo A; Xiao N; Kang J; Best CJ; Leiva I; Emmert-Buck MR; Jorcyk C; Green JE
Cancer Res; 2002 Sep; 62(18):5325-35. PubMed ID: 12235003
[TBL] [Abstract][Full Text] [Related]
4. A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line.
Zhang X; Liu Y; Gilcrease MZ; Yuan XH; Clayman GL; Adler-Storthz K; Chen Z
Cancer; 2002 Oct; 95(8):1663-72. PubMed ID: 12365014
[TBL] [Abstract][Full Text] [Related]
5. Metastatic human rhabdomyosarcoma: molecular, cellular and cytogenetic analysis of a novel cellular model.
Kalebic T; Judde JG; Velez-Yanguas M; Knutsen T; Helman LJ
Invasion Metastasis; 1996; 16(2):83-96. PubMed ID: 9030243
[TBL] [Abstract][Full Text] [Related]
6. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
[TBL] [Abstract][Full Text] [Related]
7. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
8. Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).
De Giovanni C; Nanni P; Nicoletti G; Ceccarelli C; Scotlandi K; Landuzzi L; Lollini PL
Anticancer Res; 1989; 9(6):1943-9. PubMed ID: 2516717
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase.
Collins HM; Morris TM; Watson SA
Br J Cancer; 2001 Jun; 84(12):1664-70. PubMed ID: 11401321
[TBL] [Abstract][Full Text] [Related]
10. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
11. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
Foos G; Hauser CA
Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
[TBL] [Abstract][Full Text] [Related]
12. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line.
Imai M; Muraki M; Takamatsu K; Saito H; Seiki M; Takahashi Y
BMC Cancer; 2008 Nov; 8():319. PubMed ID: 18980698
[TBL] [Abstract][Full Text] [Related]
15. Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.
Koyama S; Koike N; Adachi S
J Cancer Res Clin Oncol; 2002 Feb; 128(2):73-9. PubMed ID: 11862476
[TBL] [Abstract][Full Text] [Related]
16. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress.
Baldi A; Lombardi D; Russo P; Palescandolo E; De Luca A; Santini D; Baldi F; Rossiello L; Dell'Anna ML; Mastrofrancesco A; Maresca V; Flori E; Natali PG; Picardo M; Paggi MG
Clin Cancer Res; 2005 May; 11(9):3175-83. PubMed ID: 15867210
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel genes expressed during rhabdomyosarcoma differentiation using cDNA microarrays.
Carey KA; Segal D; Klein R; Sanigorski A; Walder K; Collier GR; Cameron-Smith D
Pathol Int; 2006 May; 56(5):246-55. PubMed ID: 16669873
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of metastasis-associated and regulatory molecules in effusions from breast cancer patients: a novel model for tumor progression.
Davidson B; Konstantinovsky S; Nielsen S; Dong HP; Berner A; Vyberg M; Reich R
Clin Cancer Res; 2004 Nov; 10(21):7335-46. PubMed ID: 15534110
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by rasV12 mutated protein and the E1A oncogene.
Vasseur S; Malicet C; Calvo EL; Labrie C; Berthezene P; Dagorn JC; Iovanna JL
Mol Cancer; 2003 Mar; 2():19. PubMed ID: 12685932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]